NCT00809068View on ClinicalTrials.gov

High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
HDL Cholesterol
Interventions
DRUG

fenofibrate and tibolone

fenofibrate 160mg daily 8 weeks tibolone 2.5mg daily 23 weeks

DRUG

tibolone

tibolone 2.5 mg daily 23 weeks

Trial Locations (1)

6009

Keogh Institute for Medical Research, 'A' Block 3rd Floor, QE II Medical Centre, Nedlands, Perth

Sponsors
All Listed Sponsors
lead

Keogh Institute for Medical Research

OTHER